Literature DB >> 25820375

Nuclear Translocation of Calpain-2 Mediates Apoptosis of Hypertrophied Cardiomyocytes in Transverse Aortic Constriction Rat.

Juan-Juan Sheng1, Hui Chang1, Zhi-Bin Yu1.   

Abstract

Apoptosis of cardiomyocytes plays an important role in the transition from cardiac hypertrophy to heart failure. Hypertrophied cardiomyocytes show enhanced susceptibility to apoptosis. Therefore, the aim of this study was to determine the susceptibility to apoptosis and its mechanism in hypertrophied cardiomyocytes using a rat model of transverse abdominal aortic constriction (TAC). Sixteen weeks of TAC showed compensatory and pathological hypertrophy in the left ventricle. TUNEL-positive nuclei were significantly increased in TAC with angiotensin II (Ang II) treatment. Calpain inhibitor, PD150606, effectively inhibited Ang II-induced apoptosis of hypertrophied cardiomyocytes. Ang II increased nuclear translocation of intracellular Ca(2+) activated calpain-2 in hypertrophied cardiomyocytes. Ang II enhanced the interaction between activated calpain-2 and Ca(2+)/calmodulin-dependent protein kinase II δB (CaMKIIδB), and promoted the degradation of CaMKIIδB by calpain-2 in the nuclei of hypertrophied cardiomyocytes. Consequently, the depressed CaMKIIδB downregulated the expression of antiapoptotic Bcl-2 leading to mitochondrial depolarization and release of cytochrome c led to apoptosis of hypertrophied cardiomyocytes. In conclusion, hypertrophied cardiomyocytes show increased susceptibility to apoptosis during Ang II stimulation via nuclear calpain-2 and CaMKIIδB pathway.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820375     DOI: 10.1002/jcp.24999

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Sustained over-expression of calpain-2 induces age-dependent dilated cardiomyopathy in mice through aberrant autophagy.

Authors:  Xiao-Yun Ji; Dong Zheng; Rui Ni; Jin-Xi Wang; Jian-Qiang Shao; Zer Vue; Antentor Hinton; Long-Sheng Song; Guo-Chang Fan; Subrata Chakrabarti; Zhao-Liang Su; Tian-Qing Peng
Journal:  Acta Pharmacol Sin       Date:  2022-08-19       Impact factor: 7.169

Review 2.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy.

Authors:  Chao Song; Jian Zhang; Yan Liu; Hao Pan; Han-Ping Qi; Yong-Gang Cao; Jian-Mei Zhao; Shang Li; Jing Guo; Hong-Li Sun; Chun-Quan Li
Journal:  Oncotarget       Date:  2016-03-08

4.  Cardiac Protection of Valsartan on Juvenile Rats with Heart Failure by Inhibiting Activity of CaMKII via Attenuating Phosphorylation.

Authors:  Yao Wu; Feifei Si; Xiaojuan Ji; Kunfeng Jiang; Sijie Song; Qijian Yi
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

Review 5.  Calcium-Sensing Receptor (CaSR)-Mediated Intracellular Communication in Cardiovascular Diseases.

Authors:  Hezhen Chu; Zhenqian Qin; Jun Ma; Yimin Xie; Haifeng Shi; Jie Gu; Baiqiang Shi
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

Review 6.  CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury.

Authors:  Yingjie Yang; Kai Jiang; Xu Liu; Mu Qin; Yaozu Xiang
Journal:  Front Mol Biosci       Date:  2021-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.